Abiopharma

NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON August 5, 2026,

Kiora Pharmaceuticals Reports its Ion Channel Modulator, KIO-300, Suppressed Seizure Activity in Preclinical Epilepsy Model

Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026

Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress

Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress

Aurora Mobile and AI Storm Enter into Business Partnership to Advance AI-Powered Customer Operations in Japan

Roma Green Finance to Receive Right of First Offer to Provide Project-Level Funding for Up to 500 Megawatts of Distributed Behind-the-Meter Data Centre Capacity in Alberta, Canada

Enanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus (RSV)

Enhanced Closes Initial Tranche of $50 Million Financing

Simply Good Foods to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, July 9, 2026